Vanguard Asset Management
KMTS

Vanguard Asset Management’s Kestra Medical Technologies KMTS Stock Holding History

Vanguard Asset Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Hold
15,363
– – ﹤0.01% 2280
2026
Q1 		$306K Buy
+15,363
New +$362K ﹤0.01% 2294

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Asset Management's KMTS Position: Q2 2026 in Review

Vanguard Asset Management held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 15,363 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #2280.

Vanguard Asset Management first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Vanguard Asset Management held 15,363 shares of Kestra Medical Technologies worth $391K as of Q2 2026.
  • Vanguard Asset Management left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #2280 holding.
  • Vanguard Asset Management first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.